BANK OF AMERICA CORP /DE/ - XORTX THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

XORTX THERAPEUTICS INC's ticker is and the CUSIP is 98420Q207. A total of 5 filers reported holding XORTX THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of XORTX THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$10.0%20.0%0.00%–
Q2 2023$10.0%20.0%0.00%–
Q1 2023$1
-50.0%
20.0%0.00%–
Q4 2022$2–2
-99.1%
0.00%–
Q3 2022$0–225
+11150.0%
0.00%–
Q2 2022$0–20.0%0.00%–
Q1 2022$0–20.0%0.00%–
Q4 2021$0–2–0.00%–
 Download
Other shareholders
XORTX THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
ROYAL BANK OF CANADA 915$1,0000.00%
UBS Group AG 5,701$8,0000.00%
BANK OF AMERICA CORP /DE/ 2$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
CIBC WORLD MARKET INC. 27,000$36,0000.00%
View complete list of XORTX THERAPEUTICS INC shareholders